Clonal Dynamics and Antimicrobial Resistance of Bloodstream Carbapenem-Resistant Acinetobacter baumannii Isolates from Korean Hospitals Between 2016 and 2020
Abstract
Background/Objective: Acinetobacter baumannii is an opportunistic pathogen responsible for various healthcare-associated infections, particularly in critically ill patients. The emergence and rapid spread of multidrug- and extensively drug-resistant strains, notably carbapenem-resistant A. baumannii (CRAB), threaten global health. We aimed to investigate the clonal distribution, antimicrobial resistance profiles, and resistance determinants of CRAB bloodstream isolates in Korean hospitals to identify emerging high-risk clones and their potential clinical impact. Methods: Sequence types (STs) were determined using the Oxford multilocus sequence typing scheme, and antimicrobial susceptibility profiles and resistance determinants were evaluated. Results: We analyzed 812 CRAB bloodstream isolates collected from nine South Korean tertiary hospitals between 2016 and 2020. The isolates were classified into 39 STs, with ST191 (n = 245) and ST369 (n = 192) being the most prevalent. Between 2016 and 2020, ST369 increased from 2.6% to 37.9%, while ST195, first detected in 2018 (0.5%), increased to 19.0%; however, ST191 declined from 45.2% to 19.0%. Most CRAB infections were hospital-acquired (91.6%, 744 of 812), predominantly affecting men aged ≥51 years, particularly the 71-80-year-olds. Resistance rates were ≥80% for ampicillin-sulbactam and ciprofloxacin. blaOXA-23 was detected in 807 isolates, confirming its central role in carbapenem resistance. ST195 exhibited higher resistance…
Read the paper
Related studies
- Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes
- Mutation supply and relative fitness shape the genotypes of ciprofloxacin-resistant Escherichia coli
- Genomic Survey of E. coli From the Bladders of Women With and Without Lower Urinary Tract Symptoms
- Characterization of cefotaxime-resistant urinary Escherichia coli from primary care in South-West England 2017–18
- Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli
- Emerging evidence-based innovative approaches to control catheter-associated urinary tract infection: a review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.